<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="https://thescipub.com/feed/aji/issue-193.rss">
<title>Volume 4, Issue 4 (2008) | American Journal of Immunology</title>
<description>Volume 4, Issue 4 (2008) | American Journal of Immunology</description>
<link>https://thescipub.com/aji/issue/193</link>
<admin:generatorAgent rdf:resource="https://thescipub.com/"/>
<admin:errorReportsTo rdf:resource="mailto:support@thescipub.com"/>
<dc:publisher>Science Publications</dc:publisher>
<dc:language>en</dc:language>
<prism:publicationName>Science Publications</prism:publicationName>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://thescipub.com/aji/ajisp.2008.43.50"/><rdf:li rdf:resource="https://thescipub.com/aji/ajisp.2008.51.65"/></rdf:Seq>
</items>
</channel><item rdf:about="https://thescipub.com/aji/ajisp.2008.43.50">
    <title><![CDATA[Voltage-Gated Channels as Causative Agents for Epilepsies]]></title>
    <link>https://thescipub.com/aji/ajisp.2008.43.50</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 December 2008; <a href="https://thescipub.com/aji/ajisp.2008.43.50">doi:10.3844/ajisp.2008.43.50</a></p>Problem statement: Epilepsy is a common neurological disorder 
that afflicts 1-2% of the general population worldwide. It encompasses a variety 
of disorders with seizures. Approach: Idiopathic epil...]]></content:encoded>
    <dc:title><![CDATA[Voltage-Gated Channels as Causative Agents for Epilepsies]]></dc:title><dc:creator>Mutasem  Abuhamed</dc:creator><dc:creator>Xiao  Bo</dc:creator><dc:creator>Kun  Xia</dc:creator><dc:creator>Yi  Fang</dc:creator><dc:creator>LiLi  Long</dc:creator><dc:identifier>doi:10.3844/ajisp.2008.43.50</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2008-12-31; | doi:10.3844/ajisp.2008.43.50</dc:source>
    <dc:date>2008-12-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2008.43.50</prism:doi>
    <prism:url>https://thescipub.com/aji/ajisp.2008.43.50</prism:url>
    </item><item rdf:about="https://thescipub.com/aji/ajisp.2008.51.65">
    <title><![CDATA[AAV-Based Targeting Gene Therapy]]></title>
    <link>https://thescipub.com/aji/ajisp.2008.51.65</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 December 2008; <a href="https://thescipub.com/aji/ajisp.2008.51.65">doi:10.3844/ajisp.2008.51.65</a></p>Since the first parvovirus serotype AAV2 was isolated from human and used as a vector for gene therapy application, there have been significant progresses in AAV vector development. AAV vectors have b...]]></content:encoded>
    <dc:title><![CDATA[AAV-Based Targeting Gene Therapy]]></dc:title><dc:creator>Wenfang  Shi</dc:creator><dc:creator>Mingxia  Yu</dc:creator><dc:creator>Qijun  Qian</dc:creator><dc:identifier>doi:10.3844/ajisp.2008.51.65</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2008-12-31; | doi:10.3844/ajisp.2008.51.65</dc:source>
    <dc:date>2008-12-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2008.51.65</prism:doi>
    <prism:url>https://thescipub.com/aji/ajisp.2008.51.65</prism:url>
    </item></rdf:RDF>